Tatva Chintan Pharma Chem Limited has informed the Exchange regarding 'Intimation under Regulation 30(5) of the Securities and Exchange Board of India("SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has filed a compliance disclosure under Regulation 30(5) of SEBI's Listing Obligations and Disclosure Requirements. This regulation requires listed companies to notify the stock exchange about the names of Key Managerial Personnel (such as the Managing Director, CFO, and Company Secretary) who have been authorised by the Board to determine the materiality of any event or information and to make timely disclosures to the exchanges. The filing itself does not announce any specific corporate event, financial result, or business development — it is a procedural/governance disclosure identifying the company's authorised signatories for materiality decisions.
This is a routine regulatory compliance filing and is not expected to have any material effect on the stock price or shareholder value. Investors need not take any action.